LegalZoom.com, Inc. (LZ)
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Investigation
09/14/2021
Initial Lawsuit
09/14/2021
Lawsuit Progression
12/08/2021
Investigation regarding Waterdrop’s statements in connection with its initial public offering (IPO), failure to comply with Chinese law and the investigation by regulatory authorities for such violations.
08/11/2021
Various news outlets, including Bloomberg, reports that China’s banking and insurance watchdog, the China Banking and Insurance Regulatory Commission, had issued an order directing insurance companies to cease improper marketing and pricing practices rampant in the industry and enhance their user privacy protections. The order reportedly stated that failure to comply would result in the offenders being “severely punished” by Chinese authorities.
“[r]egulators have since moved to shutter some operations including mutual aid healthcare platforms operated by Waterdrop.”
“In recent years, online insurance has moved into a fast lane. At the same time, transgressions have been rampant,” according to the notice, which cited offenses including some internet platforms illegally operating in insurance, mispricing risks or illicitly using client information. It called for “immediate rectification and regulation.” . . . The overhang presents multiple challenges for Waterdrop, which was one of a few Chinese fintechs to have pulled off an initial public offering this year.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$3.96 | $3.85 | $0.11 | 2.86% |
This is a securities class action on behalf of all persons or entities who purchased Waterdrop American depositary shares (ADSs) in or traceable to the Company’s May 2021 initial public offering (IPO).
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(a) that Waterdrop had achieved a substantial portion of its historical revenue growth through illicit means that ran afoul of Chinese rules and regulations governing the insurance industry;
(b) that Waterdrop had been ordered by the Chinese government to shut down its mutual aid platform because of its failure to comply with Chinese law;
(c) that Waterdrop was under investigation by regulatory authorities for continued violations of Chinese law;
(d) that, as a result of (a)-(c) above, there existed a material undisclosed risk and substantial likelihood that Waterdrop would face severe adverse actions by regulatory authorities following the IPO;
(e) that Waterdrop’s operating losses had increased more than four-fold in the first quarter of 2021 as a result of the cessation of its mutual aid business and rapidly growing customer acquisition costs; and
(f) that, as a result of (a)-(e) above, the Registration Statement’s representations regarding Waterdrop’s historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of the Company in the lead up to the IPO, were materially false and misleading, and lacked a factual basis.
12/08/2021
The court issued an order appointing the lead plaintiff and lead counsel.
02/21/2022
This is a securities class action litigation on behalf of all individuals and entities that purchased or acquired Waterdrop American depositary shares (ADSs) pursuant or traceable to the company’s false and misleading registration statement and prospectus, as amended issued in connection with Waterdrop’s May 2021 initial public offering (IPO), seeking to pursue remedies under Sections 11 and 15 of the Securities Act of 1933 against Waterdrop, certain of its officers, directors, representatives, and the underwriters of the IPO.
Operative complaint
04/22/2022
A motion to dismiss was filed with the court.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.